Etienne Pigeolet

699 total citations
15 papers, 565 citations indexed

About

Etienne Pigeolet is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Etienne Pigeolet has authored 15 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Etienne Pigeolet's work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Etienne Pigeolet is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Etienne Pigeolet collaborates with scholars based in Switzerland, France and United States. Etienne Pigeolet's co-authors include Armel Stockis, Paul Rolan, Maria Laura Sargentini‐Maier, Tom Jacobs, D. Tytgat, Sandro Gsteiger, Anne Dubois, France Mentré, Philippe Jacqmin and Sigrid Balser and has published in prestigious journals such as Neurology, Statistics in Medicine and Pharmaceutical Research.

In The Last Decade

Etienne Pigeolet

15 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etienne Pigeolet Switzerland 12 333 316 194 102 62 15 565
Maria Laura Sargentini‐Maier Belgium 15 516 1.5× 505 1.6× 286 1.5× 108 1.1× 26 0.4× 21 783
A. Rosenberg United States 12 485 1.5× 426 1.3× 227 1.2× 96 0.9× 22 0.4× 13 658
D. Tytgat Belgium 9 276 0.8× 258 0.8× 215 1.1× 67 0.7× 15 0.2× 15 507
Eugène Cox United States 12 93 0.3× 85 0.3× 79 0.4× 182 1.8× 33 0.5× 22 623
Sarah K. Tate United Kingdom 7 324 1.0× 298 0.9× 96 0.5× 186 1.8× 13 0.2× 8 805
Anitha Alex United States 13 97 0.3× 67 0.2× 105 0.5× 74 0.7× 17 0.3× 25 415
A. Tran France 9 436 1.3× 371 1.2× 127 0.7× 222 2.2× 7 0.1× 15 801
Karin Tunblad Sweden 13 112 0.3× 148 0.5× 58 0.3× 189 1.9× 11 0.2× 21 502
Takateru Ishitsu Japan 17 425 1.3× 474 1.5× 39 0.2× 273 2.7× 8 0.1× 29 767
Takayuki Seo Japan 10 314 0.9× 357 1.1× 25 0.1× 246 2.4× 5 0.1× 15 532

Countries citing papers authored by Etienne Pigeolet

Since Specialization
Citations

This map shows the geographic impact of Etienne Pigeolet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etienne Pigeolet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etienne Pigeolet more than expected).

Fields of papers citing papers by Etienne Pigeolet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etienne Pigeolet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etienne Pigeolet. The network helps show where Etienne Pigeolet may publish in the future.

Co-authorship network of co-authors of Etienne Pigeolet

This figure shows the co-authorship network connecting the top 25 collaborators of Etienne Pigeolet. A scholar is included among the top collaborators of Etienne Pigeolet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etienne Pigeolet. Etienne Pigeolet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yu, Huixin, Gordon Graham, Olivier J. David, et al.. (2022). Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis. CNS Drugs. 36(3). 283–300. 24 indexed citations
2.
Delgado, Silvia, Mitzi Williams, Morten Bagger, et al.. (2021). Comparable Ofatumumab Treatment Outcomes in Patients across Racial/Ethnic Groups in the ASCLEPIOS I/II and APOLITOS studies (4139). Neurology. 96(15_supplement). 2 indexed citations
3.
Agostini, Hansjürgen, Zufar Mulyukov, Miltiadis K. Tsilimbaris, et al.. (2020). Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data. Current Eye Research. 45(10). 1298–1301. 8 indexed citations
4.
Mulyukov, Zufar, Sebastian Weber, Etienne Pigeolet, et al.. (2018). Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect. CPT Pharmacometrics & Systems Pharmacology. 7(10). 660–669. 8 indexed citations
5.
Tsamandouras, Nikolaos, et al.. (2015). Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data. The AAPS Journal. 18(1). 196–209. 18 indexed citations
6.
Ogungbenro, Kayode, et al.. (2014). Model-Based Evaluation of the Impact of Formulation and Food Intake on the Complex Oral Absorption of Mavoglurant in Healthy Subjects. Pharmaceutical Research. 32(5). 1764–1778. 16 indexed citations
7.
Dubois, Anne, Sandro Gsteiger, Sigrid Balser, et al.. (2011). Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling. Clinical Pharmacology & Therapeutics. 91(2). 234–242. 17 indexed citations
8.
Dubois, Anne, Marc Lavielle, Sandro Gsteiger, Etienne Pigeolet, & France Mentré. (2011). Model‐based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm. Statistics in Medicine. 30(21). 2582–2600. 29 indexed citations
9.
Krzyżański, Wojciech, Paweł Wiczling, Philip J. Lowe, et al.. (2010). Population Modeling of Filgrastim PK‐PD in Healthy Adults Following Intravenous and Subcutaneous Administrations. The Journal of Clinical Pharmacology. 50(S9). 101S–112S. 36 indexed citations
10.
Wiczling, Paweł, Philip J. Lowe, Etienne Pigeolet, et al.. (2009). Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults following Intravenous and Subcutaneous Administrations. Clinical Pharmacokinetics. 48(12). 817–826. 20 indexed citations
11.
Dubois, Anne, Sandro Gsteiger, Etienne Pigeolet, & France Mentré. (2009). Bioequivalence Tests Based on Individual Estimates Using Non-compartmental or Model-Based Analyses: Evaluation of Estimates of Sample Means and Type I Error for Different Designs. Pharmaceutical Research. 27(1). 92–104. 29 indexed citations
12.
Rolan, Paul, Maria Laura Sargentini‐Maier, Etienne Pigeolet, & Armel Stockis. (2008). The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men. British Journal of Clinical Pharmacology. 66(1). 71–75. 104 indexed citations
13.
Pigeolet, Etienne, et al.. (2007). Population Pharmacokinetics of??Levetiracetam in Japanese and??Western Adults. Clinical Pharmacokinetics. 46(6). 503–512. 49 indexed citations
14.
Trenité, Dorothée Kasteleijn‐Nolst, Pierre Genton, D. Parain, et al.. (2007). Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model. Neurology. 69(10). 1027–1034. 85 indexed citations
15.
Sargentini‐Maier, Maria Laura, Paul Rolan, D. Tytgat, et al.. (2007). The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males. British Journal of Clinical Pharmacology. 63(6). 680–688. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Laura Sargentini‐Maier Breakdown of academic impact, for papers by A. Rosenberg Breakdown of academic impact, for papers by D. Tytgat Breakdown of academic impact, for papers by Eugène Cox Breakdown of academic impact, for papers by Sarah K. Tate Breakdown of academic impact, for papers by Anitha Alex Breakdown of academic impact, for papers by A. Tran Breakdown of academic impact, for papers by Karin Tunblad Breakdown of academic impact, for papers by Takateru Ishitsu Breakdown of academic impact, for papers by Takayuki Seo
Rankless by CCL
2026